Geode Capital Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-177,930
| Closed | -$541K | – | 4665 |
|
|
2023
Q4 | $541K | Buy |
177,930
+14,393
| +9% | +$43.8K | ﹤0.01% | 3584 |
|
|
2023
Q3 | $465K | Buy |
163,537
+44,505
| +37% | +$126K | ﹤0.01% | 3627 |
|
|
2023
Q2 | $309K | Hold |
119,032
| – | – | ﹤0.01% | 3841 |
|
|
2023
Q1 | $217K | Buy |
119,032
+1,900
| +2% | +$3.46K | ﹤0.01% | 4008 |
|
|
2022
Q4 | $193K | Buy |
117,132
+3,504
| +3% | +$5.77K | ﹤0.01% | 4124 |
|
|
2022
Q3 | $218K | Buy |
113,628
+36,041
| +46% | +$69.1K | ﹤0.01% | 4164 |
|
|
2022
Q2 | $231K | Sell |
77,587
-148,662
| -66% | -$443K | ﹤0.01% | 4174 |
|
|
2022
Q1 | $852K | Buy |
226,249
+88,089
| +64% | +$332K | ﹤0.01% | 3688 |
|
|
2021
Q4 | $1.57M | Buy |
138,160
+43,281
| +46% | +$492K | ﹤0.01% | 3494 |
|
|
2021
Q3 | $1.67M | Buy |
94,879
+78,599
| +483% | +$1.38M | ﹤0.01% | 3438 |
|
|
2021
Q2 | $348K | Buy |
+16,280
| New | +$348K | ﹤0.01% | 4098 |
|